Vazkepa 998 mg, Weichkapseln

7680683540012 CH-68354 Weichkapseln
Vazkepa 998 mg, Weichkapseln
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
120
Selling units
120
Measure
Kapsel(n)
Galenic form
Weichkapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ethylis icosapentas
998.0 MG Substance Wirkstoff (Principe actif)
E 307
- Substance ANTON
gelatina
- Substance HNIDK
sorbitolum liquidum non cristallisabile
- Substance HNIDK
sorbitolum
- Substance HBESI
glycerolum
- Substance HNIDK
maltitolum liquidum
- Substance HNIDK
maltitolum
- Substance HBESI
aqua purificata
- Substance HNIDK
triglycerida media
- Substance HNIDK
lecithinum ex soja
- Substance HNIDK
E 171
- Substance FNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
hypromellosum
- Substance HNIDK

Authorization holder

RECORDATI AG

4057 Basel

Authorization information

Swissmedic authorization number
68354
Drug name
Vazkepa, Weichkapseln
Galenic form
KAPWE
ATC Code
C10AX06
Authorization status
Z
Dispensing category
B
First authorization
22/11/2022
Authorization expiration date
21/11/2027
IT Number
07.12.0.
Domain
Human medicine
Field of application
Blutlipidsenkende Mittel

Package details

Description (FR)
VAZKEPA caps moll 998 mg bte 120 pce
Description (DE)
VAZKEPA Weichkaps 998 mg Ds 120 Stk
Market launch
22/11/2022
Narcotic (BTM)
No

Other package sizes (2)

None
4 x 2 KAP
GTIN: None
Not in V1
VAZKEPA caps moll 998 mg bte 360 pce
360 KAP
GTIN: 7680683540036
View
Buy us a coffee Explore the data